KVISTGÅRD/HUMLEBÆK DYREKLINIKKER ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 2.0% 2.7% 3.4% 1.1%  
Credit score (0-100)  70 68 59 54 83  
Credit rating  A A BBB BBB A  
Credit limit (kDKK)  0.3 0.4 0.0 0.0 224.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  3,316 3,775 5,349 -148 -36.8  
EBITDA  762 757 3,351 -156 -36.8  
EBIT  689 666 3,351 -156 -36.8  
Pre-tax profit (PTP)  682.2 650.6 3,591.6 202.4 627.0  
Net earnings  543.2 503.4 2,847.8 228.8 617.9  
Pre-tax profit without non-rec. items  682 651 3,592 202 627  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  233 171 0.0 0.0 0.0  
Shareholders equity total  1,025 1,329 4,077 4,214 4,752  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,728 2,726 4,549 4,519 4,839  

Net Debt  -1,309 -2,365 -2,323 -1,850 -3,630  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,316 3,775 5,349 -148 -36.8  
Gross profit growth  39.4% 13.8% 41.7% 0.0% 75.1%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,728 2,726 4,549 4,519 4,839  
Balance sheet change%  41.7% 57.8% 66.9% -0.7% 7.1%  
Added value  761.8 756.9 3,351.3 -155.8 -36.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  65 -153 -171 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.8% 17.6% 62.7% 105.3% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  46.8% 29.9% 99.0% 4.9% 13.5%  
ROI %  92.2% 56.5% 130.5% 5.3% 14.1%  
ROE %  72.7% 42.8% 105.3% 5.5% 13.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  59.3% 48.8% 89.6% 93.3% 98.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -171.9% -312.5% -69.3% 1,187.2% 9,853.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.0 1.8 9.8 10.8 42.3  
Current Ratio  2.1 1.8 9.8 10.8 42.3  
Cash and cash equivalent  1,309.3 2,365.3 2,323.2 1,849.9 3,630.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  792.3 1,158.3 3,188.4 2,983.2 1,119.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -37  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -37  
EBIT / employee  0 0 0 0 -37  
Net earnings / employee  0 0 0 0 618